[1] LIN WW,HSIEH SL.Decoy receptor 3:a pleiotropic immunomodulator and biomarker for inflammatory diseases,autoimmune diseases and cancer[J].Biochem Pharmacol,2011,81(7):838.
[2] GE Z,SANDERS AJ,YE L,et al.Aberrant expression and function of deathreceptor-3 and death decoy receptor-3 in human cancer[J].Exp Ther Med,2011,2(2):167.
[3] ZHAN C,PATSKOVSKY Y,YAN Q,et al.Decoy strategies:the structure of TL1A:DcR3 complex[J].Structure,2011,19(2):162.
[4] SIAKAVELLAS SI,SFIKAKIS PP,BAMIAS G.The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases[J].Semin Arthritis Rheum,2015,45(1):1.
[5] YAMADA D,ASANO Y,TAKAHASHI T,et al.Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosis[J].Eur J Dermatol,2012,22(3):351.
[6] MARUYAMA H,HIRAYAMA K,NAGAI M,et al.Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis[J].Clin Rheumatol,2016,35(10):2469.
[7] LIU J,ZHAO Z,ZOU Y,et al.The expression of death decoy receptor 3 was increased in the patients with primary Sj gren's syndrome[J].Clin Rheumatol,2015,34(5):879.
[8] 杜欢,许霞.近5年来类风湿关节炎发病机制研究进展[J].辽宁中医药大学学报,2015,17(10):77.
[9] YANG CR,WANG JH,HSIEH SL,et al.Decoy receptor3(DcR3) induces osteoclast formation from monocyte/macrophage lineage precursorcells[J].Cell Death Differ,2004,11(1):97.
[10] HAYASHI S,MIURA Y,TATEISHI K,et al.Decoy receptor 3 is highly expressedinpatients with rheumatoid arthritis[J].Mod Rheumatol,2010,20(1):63.
[11] CHEN MH,LIU PC,CHANG CW,et al.Decoy receptor 3 suppresses B cell functions and has a negative correlation with disease activity in rheumatoid arthritis[J].Clin Exp Rheumatol,2014,32(5):715.
[12] 周玉秀,刘恩令,柴连.DcR 3在类风湿关节炎的表达及其临床意义[J].中国免疫学杂志,2014,30(9):1253.
[13] XIU Z,SHEN H,TIAN Y,et al.Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis[J].Cytokine,2015,72(2):185.
[14] 贾汝琳,赵静,孙晓麟,等.类风湿关节炎病人血清中诱骗受体3的检测及临床意义[J].中华风湿病学杂志,2013,17(1):20.
[15] 孙可歆,赵臣,李艳,等.RA病人外周血DcR3表达水平与疾病活动性相关分析[J].中国实验诊断学,2012,16(11):2069.
[16] 崔会玲,王婷.检测类风湿关节炎病人血清DcR3、IL-4和IFN-γ免疫的临床意义[J].中国卫生检验杂志,2014,24(24):3565.
[17] HERMAN S,ZURGIL N,LANGEVITZ P,et al.Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patients[J].Clin Exp Rheumatol,2008,26(2):317.
[18] 孙可歆,李春辉,郭素红.类风湿性关节炎病人外周血单个核细胞DcR3基因表达水平的分析[J].中国现代药物应用,2013,7(8):1.